BioRestorative Therapies (BRTX) 10-K2018 FY Annual report

Filed: 29 Mar 19, 5:24pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: absorption, abuse, abusive, AKS, Albany, Alstodt, arsenal, banker, Biochem, Biogen, Bioscience, Bipartisan, Boston, breadth, breakthrough, Brigham, Broadrick, Budget, cap, charitable, Chase, choose, Christopher, complicating, Congressional, construct, count, Curative, cure, Dale, degeneration, derecognition, Dermstadt, detain, developmental, dosage, Eagle, ECO, efficient, EMD, entrepreneurial, ENZ, Enzo, excretion, Fast, faster, foot, forfeited, formulary, frequency, Geduld, Gerard, Germany, GLP, GMP, Harvey, Harvinder, Head, Hofstra, Idec, immunohematology, incentive, indeterminable, inhibit, input, Inspector, intentional, interviewed, irreversible, Jason, Jersey, Justice, KGaA, lab, Lance, larger, Lerrink, lessee, leveraged, Lipetz, lumbosacral, Lynch, Malanga, MBA, meaningful, meant, MedVest, Melody, Merrill, MFN, Millennium, mirrored, misconduct, Mitigation, molecule, morbidity, Morgan, mortality, MossRehab, narrative, narrow, narrower, neurodegenerative, Neurotrope, nonemployee, Northwell, NYSE, Offshore, Oppenheimer, optimistic, orchestrated, orthopedic, overlap, Paccasassi, payer, penalty, Penn, percent, Physiatrist, PPACA, preliminary, prescribe, prevalence, proactive, Programhave, Programwere, proposition, rarity, reclassification, recognizable, recommend, recomputed, referral, Rhode, rolling, sampling, Sandhu, SCG, seize, sequencing, Serono, Sound, spent, Steven, strict, sum, supplement, supplemental, Surgeon, surveillance, switched, Task, Taxpayer, Technologist, theJournal, thirty, tolerable, tolerance, unacceptably, unanticipated, undiscounted, unfavorably, unmanaged, unmet, unrealized, unused, unvested, vii, viii, voluntary, Women, Young

Removed: accessed, administer, aggregating, bagel, Big, broadened, called, capability, cGCP, chain, clinician, commented, contractor, Cooperation, Council, CSH, declaring, disqualification, EDPAB, electronic, factor, format, founded, fourth, franchised, Gene, gesture, Gesturetek, hereof, impermissibly, inactive, incubator, inside, interactive, interpretation, interstate, introducing, Israel, Jestertek, judicial, kind, label, mailed, mandate, markdown, markup, merger, month, nonclinical, notified, NYEPI, NYS, ofStem, originally, paying, payor, PCT, pioneering, procurement, prohibited, redirected, residence, restitution, retaining, safeguarding, secure, shipped, Simplification, skincare, spend, subcontractor, sufficiently, thawed, theAdministrative, theSecurity, transferred, transmitting, Treaty, upscale, utilized, video

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BRTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.13

BioRestorative Therapies, Inc.

40 Marcus Drive, Suite One

Melville, New York 11747

January 5, 2018

Mr. Francisco Silva

10 Flyers Lane

Tustin, California 92782

Dear Mr. Silva:

Reference is made to the Amended and Restated Executive Employment Agreement, dated as of May 10, 2011, between BioRestorative Therapies, Inc. (formerly known as Stem Cell Assurance, Inc.) and Francisco Silva, as amended (the “Employment Agreement”).

The parties hereby agree that, effective as of January 1, 2018, the “Per Annum Salary” in Schedule A of the Employment Agreement is amended to read as follows:

“Per Annum Salary: $287,500”

Except as amended hereby, the Employment Agreement shall continue in full force and effect in accordance with its terms.

	Very truly yours,

	BioRestorative Therapies, Inc.

	By:
		Mark Weinreb, Chief Executive Officer

Agreed:


Francisco Silva